William C. Olson is Senior VP & Research and Develo at PROGENICS PHARMACEUTICALS INC (PGNX). They have made 1 open-market trade across 1 company since 2006, most recently 2012-06-20.
CIK 0001327414
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNX | 45,544 | $187K |
Shares reported on the most recent Form 4, priced at the 2012-06-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNX | SELL · 10b5-1 | 2011-06-21 | 2011-06-22 | $7.09 | $20K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL | 2010-06-22 | 2010-06-24 | $5.81 | $14K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2009-06-23 | 2009-06-24 | $4.73 | $12K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2007-12-03 | 2007-12-05 | $19.03 | $76K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2006-06-20 | 2006-06-22 | $21.62 | $22K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2006-05-04 | 2006-05-08 | $24.00 | $336K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2006-03-20 | 2006-03-21 | $27.46 | $55K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2006-02-21 | 2006-02-23 | $28.01 | $56K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2006-02-06 | 2006-03-01 | $24.45 | $49K | -27.5% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.